What is the prevalence of Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency?

Mendelian susceptibility to mycobacterial diseases (MSMD) is a rare genetic disorder characterized by an increased susceptibility to severe infections caused by certain mycobacteria, including Mycobacterium tuberculosis and Bacillus Calmette-Guérin (BCG) vaccines. MSMD can be caused by various genetic mutations, including partial STAT1 deficiency.

Partial STAT1 deficiency refers to a specific type of genetic mutation affecting the signal transducer and activator of transcription 1 (STAT1) protein. This mutation leads to a partial impairment of the immune response, particularly in the interferon-gamma (IFN-γ) signaling pathway. IFN-γ plays a crucial role in the defense against mycobacterial infections.

The prevalence of MSMD due to partial STAT1 deficiency is relatively low. It is estimated to affect a small percentage of the population, with reported cases primarily found in certain geographic regions or specific ethnic groups. Due to its rarity, the exact prevalence is not well-documented.

Individuals with partial STAT1 deficiency are more susceptible to mycobacterial infections, which can manifest as severe or recurrent diseases. Prompt diagnosis and appropriate management are crucial to prevent complications and provide targeted treatment.

It is important to consult with a healthcare professional or genetic specialist for a comprehensive evaluation and genetic testing if there is a suspicion of MSMD or partial STAT1 deficiency.